Topline data were announced from a phase 3 trial evaluating orforglipron in adults with T2D and inadequate glycemic control with diet and exercise alone.

Vision loss, thyroid tumours, kidney problems, gallbladder issues and pancreatitis are some of the concerning side effects ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

(Nasdaq: IBIO), an AI-driven innovator of precision antibody therapies, today announced a licensing agreement with AstralBio ...

Novo Nordisk filed for approval of an oral, 25-mg formulation of semaglutide “earlier this year,” according to a company spokesperson.

Dispensations of tirzepatide and semaglutide increased significantly in recent years while the use of other glucose-lowering ...

From cayenne pepper to berberine, here are four essential herbs that are great for weight loss and metabolism support.

Plus, salon owners are seeing a massive drawdown in clients coming in for their regular scheduled appointments, citing ...

Fruitist, known for its jumbo blueberries, has surpassed $400 million in annual sales and received backing from Ray Dalio’s ...

The former CEO of the collagen company is now leading Supergut, which plays in an emerging but competitive category of ...

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

Researchers link GLP1 agonists to depression risk in some users and call for personalized prescribing based on genetic ...